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Preserved Endothelium-Dependent Vasodilation in Coronary
Segments Previously Treated With Balloon Angioplasty and
Intracoronary Irradiation
Manel Sabate´, MD; I. Patrick Kay, MBChB; Willem J. van der Giessen, MD, PhD;
Angel Cequier, MD, PhD; Jurgen M.R. Ligthart, BSc; Joan Antoni Go´mez-Hospital, MD;
Ste´phane G. Carlier, MD; Veronique L.M.A. Coen, MD; Johannes P.A. Marijnissen, PhD;
Alexander J. Wardeh, MD; Peter C. Levendag, MD, PhD; Patrick W. Serruys, MD, PhD
Background—Abnormal endothelium-dependent coronary vasomotion has been reported after balloon angioplasty (BA),
as well as after intracoronary radiation. However, the long-term effect on coronary vasomotion is not known. The aim
of this study was to evaluate the long-term vasomotion of coronary segments treated with BA and brachytherapy.
Methods and Results—Patients with single de novo lesions treated either with BA followed by intracoronary b-irradiation
(according to the Beta Energy Restenosis Trial-1.5) or with BA alone were eligible. Of these groups, those patients in
stable condition who returned for 6-month angiographic follow-up formed the study population (n519, irradiated group
and n511, control group). Endothelium-dependent coronary vasomotion was assessed by selective infusion of serial
doses of acetylcholine (ACh) proximally to the treated area. Mean luminal diameter was calculated by quantitative
coronary angiography both in the treated area and in distal segments. Endothelial dysfunction was defined as a
vasoconstriction after the maximal dose of ACh (1026 mol/L). Seventeen irradiated segments (89.5%) demonstrated
normal endothelial function. In contrast, 10 distal nonirradiated segments (53%) and 5 control segments (45%)
demonstrated endothelium-dependent vasoconstriction (219617% and 29.065%, respectively). Mean percentage of
change in mean luminal diameter after ACh was significantly higher in irradiated segments (P50.01).
Conclusions—Endothelium-dependent vasomotion of coronary segments treated with BA followed by b-radiation is
restored in the majority of stable patients at 6-month follow-up. This functional response appeared to be better than those
documented both in the distal segments and in segments treated with BA alone. (Circulation. 1999;100:1623-1629.)
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Abnormal endothelium-dependent coronary vasomotionhas been reported both immediately after and up to 6
months after coronary balloon angioplasty (BA).1–4 The
preservation of endothelial function is of the utmost impor-
tance to maintain the delicate balance between inhibition and
promotion of vascular growth, vasoconstriction, and vasodi-
lation, as well as antithrombotic and hemostatic mecha-
nisms.5 Intracoronary radiation appears to be a promising new
technique to prevent restenosis after BA.6–8 Experimental
studies have demonstrated an impairment of endothelial
function in the short term after high-dose intracoronary
g-irradiation, which was restored at follow-up.9 However, the
effect of brachytherapy after balloon-induced injury on vaso-
motor function in patients remains unknown. The aim of the
present study was to assess the long-term effect of intracor-
onary radiation therapy after successful BA on coronary
vasomotion.
Methods
Patient Selection
Two groups of patients were compared: patients with single de novo
lesions successfully treated with BA followed by intracoronary
b-irradiation (n523) and patients with single de novo lesions
successfully treated only with BA (n516). Patients receiving radia-
tion were included in the Beta Energy Restenosis Trial (BERT-1.5).
Patients in the control group were individuals treated with BA alone
and matched for age, sex, and vessel size. Those patients in stable
condition who returned for 6-month angiographic follow-up formed
the study population (n519, irradiated group and n511, control
group). BERT-1.5 was a prospective multicenter feasibility study.
The isotope selected was pure b-emitting 90Sr/90Y, and patients were
randomized to receive 12, 14, or 16 Gy at 2 mm from the source. The
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inclusion and exclusion criteria of this trial have been reported
previously.10
Radiation Delivery System
The Beta-Cath System (Novoste Corp) was used to deliver localized
b-radiation to a coronary artery at the site of coronary intervention.
The device consists of 3 components: (1) the transfer device, which
stores the radiation source train and allows the positioning of these
sources within the catheter; (2) the delivery catheter, which is a 5F
multilumen, over-the-wire, noncentered catheter that uses saline
solution to send and return the radiation source train; and (3) the
radiation source train, which consists of a series of 12 independent
2.5-mm-long cylindrical seeds that contain the radioisotope 90Sr/90Y
sources and is bordered by 2 gold radiopaque markers at the distal
and proximal parts of the 30-mm source train.11
Dose Calculation
The actual dose received by the luminal surface was retrospectively
calculated by means of dose-volume histograms.12 This method is
based on quantitative intravascular ultrasound (IVUS) under the
assumption that the radiation source is positioned at the same place
as the IVUS catheter. The method of selection of the area of interest
on IVUS has been reported previously.13 The IVUS system used was
a sheath-based IVUS catheter (ClearView, CVIS, Boston Scientific
Corporation) incorporating a 30-MHz single-element transducer
rotating at 1800 rpm (Ultracross, CVIS). Image acquisition and
digitization were performed by means of an ECG-gated pullback at
a step size of 0.2 mm/step.14,15 Volumetric analysis of the irradiated
area was performed by a semiautomatic contour detection program
developed at our institution.16 The feasibility and intraobserver and
interobserver variabilities of this system have been reported previ-
ously.17–19 The distance between the center of the catheter and both
the lumen-intima and media-adventitia interfaces was calculated in
24 pie slices (15° each) in all cross sections corresponding to the
irradiated area (30-mm length of the train source). Considering the
prescribed dose and the accurate geometric data obtained from
the IVUS, the cumulative curve of the dose-volume histogram for a
predefined volume (ie, intima or adventitia) can be obtained (Figure
1). From this curve, for example, the minimal dose received by 90%
of either the intimal volume (Dv90 lumen) or the adventitial volume
(Dv90 Adv) was calculated.
Endothelial Function Study
Long-acting vasoactive drugs were discontinued $48 hours before
the study. A percutaneous femoral artery approach and 8F guiding
catheter were used in all cases. Endothelium-dependent and
-independent coronary vasomotion were studied as described previ-
ously in detail20: after the administration of 10 000 IU of heparin, a
3F infusion catheter (Transit, Cordis) was advanced over a guidewire
and placed proximally to the irradiated segment. To avoid wire-
induced coronary spasm, the wire was removed. The irradiated
segment was identified on the basis of the anatomic landmarks
visible on the angiogram performed at the time of the placement of
the radiation source. To ensure that the segments were fully bathed
by the infusion of acetylcholine chloride (ACh), the tip of the
infusion catheter was placed 2 to 3 mm proximal to the proximal
border of the irradiated area. To determine the baseline vasomotion,
an initial infusion of saline solution for 1 minute through the infusion
catheter was performed and a baseline angiogram taken. This was
followed by infusion of serial doses of intracoronary ACh, with final
estimated intracoronary concentrations of 1028 to 1026 mol/L, to
assess endothelium-dependent coronary vasomotion. The duration of
each infusion was 2.5 minutes, followed immediately by angiogra-
phy. All angiograms were taken with identical views and radiograph-
ic characteristics. All infusions were delivered at a rate of 2 mL/min
by use of a precision pump injector (Mark V, Medrad, Europe BV).
The final blood concentrations of ACh were estimated with the
assumption that blood flow in the coronary artery was 80 mL/min.21
Finally, to evaluate endothelium-independent vasomotion, a nitro-
glycerin (NTG) bolus (2 mg) was administered through the guiding
catheter, after which an angiogram identical to those performed
previously was done.20 Throughout each infusion, the heart rate,
systemic arterial pressure, and ECG were monitored continuously.
Because ACh causes endothelium-dependent vessel relaxation in
experimental models and in humans,22,23 a paradoxical vasoconstric-
tion after the infusion of this substance is an indicator of endothelial
dysfunction.20
The study was approved by the Medical Ethics Committee of our
institution, and written informed consent was obtained from all
patients in accordance with the guidelines established by the Com-
mittee for the Protection of Human Subjects.
Quantitative Coronary Angiography
Quantitative coronary angiography was performed after the infusion
of saline solution, at the end of each ACh infusion, and after NTG
bolus. Angiograms were performed in the 2 orthogonal projections
that best showed the artery of interest, without overlapping of side
branches and with less foreshortening. Offline analysis was per-
formed by means of the CAAS II system (Pie Medical BV).
Calibration of the system was based on dimensions of the catheters
not filled with contrast medium. The intraobserver and interobserver
variabilities of this method of analysis have been reported previous-
ly.24–26 Mean luminal diameter was determined after the infusion of
each substance in the irradiated area, in a 15- to 20-mm-long
segment distal to the irradiated area and in a contralateral nontreated
artery that served as a control. Mean luminal diameter was averaged
for the 2 projections, and the percentage of change relative to
baseline was noted. All quantitative measurements were performed
by the same investigator (M.S.). Intraobserver variability was as-
sessed by reanalysis of the quantitative coronary angiography of a
series of 15 studies (150 repeated measures in total) $3 months
apart. Intraobserver differences (mean62 SD) in mean luminal
diameter were as follows: 0.762.7% for baseline values, 0.862.9%
after maximal dose of ACh, and 0.762.6% after NTG. The intraclass
correlation coefficient (R2) for repeated measures was 0.97 for
baseline values, 0.96 for maximal-dose ACh values, and 0.98 for
NTG values. We considered endothelial dysfunction a vasoconstric-
tion of the segment studied after the maximal dose of ACh beyond
the variability of the method of analysis (.3%).
Statistical Analysis
Data are presented as mean6SD or proportions. To compare
continuous variables, 2-tailed Student’s t test, ANOVA for repeated
measurements, and linear regression analysis were performed when
appropriate. A value of P,0.05 was considered statistically
significant.
Figure 1. Dose-volume histogram showing cumulative dose
received at level of luminal surface and adventitia layer. Minimal
dose received by 90% of lumen (Dv90 Lumen) and adventitia
(Dv90 Adv) was calculated.
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Results
Baseline Characteristics
Baseline characteristics of both irradiated and control patients
are presented in Table 1. Angiographic restenosis (diameter
stenosis .50%) was observed within the irradiated area in 3
patients (16%). Fourteen patients (74%) remained asymptom-
atic, whereas 5 (26%) presented with angina pectoris Cana-
dian Cardiovascular Society (CCS) class 1 (n51), 2 (n51), or
3 (n53). None of the patients in the control group showed
angiographic restenosis, and only 2 presented with angina
pectoris CCS class 1. No differences were observed between
groups regarding age, sex, coronary risk factors, or minimal
luminal diameter and diameter stenosis in the diagnostic
angiogram performed at the time of the functional study. The
left anterior descending coronary artery was assessed more
often in the control group.
Coronary Vasomotion Study
No significant changes in mean aortic pressure and heart rate
were observed during the ACh infusion in either group. Mean
luminal diameters after infusion of each substance in irradi-
ated and distal nonirradiated segments and in the control
group are presented in Table 2. Seventeen irradiated segments
(89.5%) demonstrated normal endothelium-dependent coro-
nary vasomotion (16 segments with a vasodilatory response
[5.063% of change in mean luminal diameter after Ach] and
1 with no change in mean luminal diameter [–0.1% of change
after Ach infusion]). On the other hand, endothelial dysfunc-
tion was demonstrated in 2 irradiated segments (10.5%): 1
with angiographic restenosis and angina pectoris CCS class 3
and the other with angina pectoris CCS class 1 without
restenosis (–5.2% and –7.8% of vasoconstriction after max-
imal dose of ACh, respectively). In contrast, 10 (53%) of the
distal nonirradiated segments demonstrated endothelial dys-
function (–19.5617% of vasoconstriction after maximal dose
of ACh). No significant de novo stenosis was observed at
distal segments. No significant correlation was demonstrated
between the degree of stenosis at follow-up and the vasomo-
tor response. Five patients in the control group (45%) showed
endothelial dysfunction in the treated area (–9.065% of
vasoconstriction at ACh 1026 mol/L). Mean percentages of
change in mean luminal diameter after infusion of the
different substances between the irradiated and control pa-
tients and between irradiated and distal nonirradiated seg-
ments are presented in Figures 2 and 3. Mean percentage
change in diameter after ACh was 3.867.1% in the irradiated
segments compared with 23.267% and 26.6610% in the
control group and in the distal nonirradiated segments,
respectively (P50.01). No significant differences in percent-
age of change in mean luminal diameter either in irradiated or
in distal segments were observed between the 3 coronary
vessels after either ACh or NTG. Examples of coronary
segments with vasodilation of the irradiated area and vaso-
constriction of the distal nonirradiated segment after ACh
infusion are depicted in Figures 4 and 5. All of the segments
experienced vasodilation after NTG, which is indicative of
normal smooth muscle vasomotion (Figures 2 and 3).
Radiation Dose Calculation
Mean prescribed radiation dose was 1461.9 Gy at 2 mm to
the source. However, when dose-volume histograms were
applied, the calculated minimal dose received by 90% of the
Figure 2. Percentage of change in mean luminal diameter after
infusion of each substance in irradiated segments and in control
group. Irradiated segments showed, on average, an increase in
mean luminal diameter after infusion of ACh, which is indicative
of normal endothelial function, whereas control group demon-
strated on average vasoconstriction, which is indicative of endo-
thelial dysfunction. Endothelium-independent coronary vasomo-
tion was preserved in both groups. BL indicates baseline.
TABLE 2. Coronary Vasomotor Response (Mean
Luminal Diameter)
Irradiated Segment
(n519)
Distal
Segment
(n519)
Control
Group
(n511)
Baseline 2.4660.4 2.2060.4 2.3860.3
ACh 1028 2.4960.4 2.1960.5 2.3560.3
ACh 1027 2.5260.4 2.1360.5 2.3360.5
ACh 1026 2.5560.5* 2.0760.7 2.3160.3
NTG 2.6260.4† 2.3360.6‡ 2.5860.5‡
Data are presented as mean6SD (in mm).
*P50.03, †P50.0004, ‡P50.01 with respect to baseline values.
TABLE 1. Baseline Characteristics
Irradiation Group
(n519)
Control Group
(n511)
Age, y 5568 5865
Male sex, n (%) 14 (74) 10 (91)
Treated artery, n (%)
Left anterior descending 10 (53) 10 (91)
Left circumflex 6 (31) 1 (9)
Right coronary 3 (16) 0 (0)
Coronary risk factors, n (%)
Systemic hypertension 9 (47) 5 (45)
Diabetes mellitus 2 (10) 1 (9)
Smoking 14 (74) 7 (63)
Hypercholesterolemia 11 (58) 6 (54)
Family history 11 (58) 5 (45)
Minimal luminal
diameter, mm
1.760.6 1.660.3
Diameter stenosis, % 39617 3467
Continuous data are presented as mean6SD.
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luminal surface was 8.263.8 Gy, whereas DV90 Adv was
5.261.9 Gy. Only 6 patients (31.5%) received on average
.10 Gy at luminal surface, and only 2 patients (10.5%)
received on average .8 Gy at the adventitial layer. No
significant correlation was found between endothelium-
dependent coronary vasomotion and the calculated Dv90 lu-
men (r520.03; P5NS). Similarly, no significant correlation
was observed between the coronary vasomotor response to
NTG and Dv90 Adv (r50.03; P5NS).
Discussion
This study demonstrates for the first time that the endotheli-
um-dependent vasomotor function of coronary segments
treated with BA followed by b-radiation is restored in the
majority of stable patients at 6-month follow-up. This func-
tional response observed in irradiated segments appeared to
be better than that documented both in distal nonirradiated
segments and in segments treated only with BA.
An impairment of endothelial function has been reported at
up to 3 to 6 months after BA.4 It has been demonstrated that
soon after balloon-induced injury, there is a release of von
Willebrand factor27 and endothelin28 as markers of endothe-
lial injury. Experimental studies have demonstrated that the
endothelium regenerates at follow-up. However, the endothe-
lium appeared to still be dysfunctional,29,30 which may cause
the release of endothelium-dependent contracting factors and
the alteration of endothelial muscarinic receptors.31–33
Endothelial dysfunction in distal nontreated segments is a
common finding in atherosclerotic coronary arteries after
percutaneous interventions.3 An alteration of autoregulation
due to chronic hypoperfusion may be implicated in the distal
abnormal responsiveness to ACh.2 Furthermore, the presence
of coronary risk factors may have a deleterious effect on
distal coronary vasomotion.34,35
In contrast, most of the irradiated segments exhibited
normal endothelium-dependent vasomotion, and all of them
presented a normal response to NTG. Wiedermann et al9
demonstrated restoration of endothelial function after high-
dose (20 Gy) g-radiation in a non–balloon-injured animal
model. However, a diffuse fibrosis of the smooth muscle
layer, probably responsible for the loss of response to NTG,
was detected on histological analysis.9 Our findings con-
firmed these experimental observations in terms of endothe-
lium-dependent coronary vasomotion. The lack of paradoxi-
cal vasoconstriction may be explained by an alteration of the
muscular media, which may demonstrate an impairment in
response to endothelium-dependent vasoregulatory signals.
However, vasodilation rather than lack of constriction was the
vasomotor response demonstrated in all but 1 of the irradiated
segments with normal endothelial function. The vasomotor
response to NTG remained unaltered and comparable be-
tween groups, which suggests an absence of radiation-
induced impairment of the medial layer. In an experimental
model, endothelial cells as well as vascular smooth muscle
cells were inhibited in a dose-dependent manner. However, at
a moderate range of b-particle delivery (0.4 to 6 Gy), but not
at a high dose (10 Gy), endothelial cells appeared to be more
radioresistant than vascular smooth muscle cells.36 The rela-
tively low dose of radiation received by the treated segments
may account for this normal functional behavior. In fact, none
Figure 4. Coronary angiogram showing mild vasodilation in irra-
diated segment at 6-month follow-up.
Figure 3. Percentage of change in mean luminal diameter after
infusion of each substance in irradiated and in distal nonirradi-
ated segments. Irradiated segments showed, on average, an
increase in mean luminal diameter after infusion of ACh, which
is indicative of normal endothelial function, whereas distal nonir-
radiated segments demonstrated, on average, vasoconstriction,
which is indicative of endothelial dysfunction. Endothelium-
independent coronary vasomotion was preserved in both
groups. BL indicates baseline.
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of the patients actually received on average .10 Gy at the
level of the adventitia, as assessed by dose-volume
histograms.
On the other hand, an experimental model of porcine
coronary arteries subjected to balloon overstretch injury and
either placebo or radiation with 18 Gy37 demonstrated that
expression of enzyme-inducible nitric oxide synthase (iNOS),
responsible for NO production, was enhanced, whereas ex-
pression of the cytokine transforming growth factor-b1 (TGF-
b1) was suppressed in the irradiated group. iNOS is poten-
tially responsible for inhibition of neointimal hyperplasia and
stimulation of reendothelialization, whereas TGF-b1 would
enhance intimal hyperplasia and fibrosis by negatively mod-
ulating the expression of iNOS.37 Moreover, it has been
demonstrated in experimental models that radiation causes
dose- and time-dependent impairment of endothelium-
dependent relaxation38 and that low-dose radiation would
induce an anti-inflammatory reaction through specific dose-
dependent modulation of the NO pathway.39 It remains to be
seen whether this chain reaction after radiation would result
in a late reduction in the restenosis rate. However, restoration
of endothelial function may play an important role in this
regard.
Study Limitations
Because the use of ACh in unstable patients is not exempt of risk
of coronary occlusion, only stable patients were evaluated.
This study assessed patients receiving b-radiation by
means of a noncentering device. The actual dose received by
the treated segment was rather low; thus, the effect of a higher
dose or of different devices that allow a more homogeneous
dose distribution remains to be evaluated.
We assessed the vasomotion of the 3 coronary arteries in
the irradiated group, which have a potentially different degree
of vasoreactivity to ACh. However, the 3 arteries demon-
strated comparable vasomotor responses to ACh and NTG
both at the irradiated and the distal segments, which over-
comes this potential limitation.
We assumed that coronary vasomotion immediately after
treatment is markedly impaired, as demonstrated in experi-
mental models and in humans.1–4,9 Taking into account the
risk of coronary occlusion in such situation, it was considered
unethical to determine endothelium-dependent vasomotion
immediately after the coronary intervention. Thus, the degree
of recovery of coronary vasomotion could not be evaluated.
We also assumed that the IVUS and delivery catheters
were lying in the same position in the treated coronary
Figure 5. Coronary angiogram showing moderate vasoconstriction of distal nontreated coronary segment after infusion of maximal
dose of ACh, which is indicative of endothelial dysfunction.
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segment. The size of the IVUS catheter is smaller (2.9F,
'1 mm) than the brachytherapy device (5F), which is thus to
some extent more centered in the lumen. Although the
catheters should be on the shortest 3D path in the lumen,
coronary arteries have a complex curved geometry in space
and can be partially deformed by the catheters. Thus, cathe-
ters with different rigidity may occupy different positions.
The development of new systems that incorporate the IVUS
imaging element on the delivery catheter might resolve this
drawback.
During irradiation, the position of the delivery catheter
inside the lumen is not fixed and may vary during the cardiac
cycle because of ventricular contractions, which may lead to
some degree of inhomogeneity not assumed by data derived
from the static end-diastolic IVUS images.
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